Home Alone Program for Cognitive Impairment
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to evaluate a program for adults who live alone and have some cognitive impairment (CI) to see if it is useful and acceptable. This program aims to help older adults with cognitive impairment who live alone to be engaged and active, as well as safe at home. The investigators want to see how useful this program is and how it can be improved. The specific aims are: * Specific Aim 1: Develop and Adapt Home Alone to Prepare for Pilot Testing. * Specific Aim 2: Pilot Test a Revised Version of Home Alone. Phase I participants will be asked to: * Participate for 3 months * Complete 3 surveys * Complete 7 1-hour meetings on a weekly basis with a coach * Complete a final interview Phase II participants will be asked to: * Participate for 6 months * Complete 3 surveys * Complete 7 1-hour meetings on a weekly basis with a coach * A sub-sample will be asked to complete a final interview
Will I have to stop taking my current medications?
The trial requires that participants have been on a stable dosage of psychotropic medications (like antidepressants or anti-anxiety drugs) for the past three months, so you may need to maintain your current medication regimen.
What data supports the effectiveness of the Home Alone treatment for cognitive impairment?
Research on similar home-based cognitive interventions shows that they can help improve cognitive function and emotional well-being in elderly individuals living alone. Additionally, programs like the Home Independence Program have shown improvements in functional abilities and confidence in performing everyday activities.12345
Is the Home Alone Program for Cognitive Impairment safe for humans?
The available research does not provide specific safety data for the Home Alone Program for Cognitive Impairment, but it highlights general safety concerns for older adults living alone with cognitive impairment, such as risks of injury and medication errors. These studies suggest that interventions like remote monitoring and home modifications can help improve safety for this population.678910
How is the Home Alone treatment different from other treatments for cognitive impairment?
The Home Alone treatment is unique because it focuses on providing support and cognitive interventions directly in the home for individuals living alone, which can help reduce feelings of loneliness and isolation that contribute to cognitive decline. This approach is different from traditional treatments that may not address the specific challenges faced by those living alone.35111213
Research Team
Joseph Gaugler, PhD
Principal Investigator
University of Minnesota
Eligibility Criteria
This trial is for U.S. residents aged 55 or older who live alone, can consent to participate, and have cognitive impairment (CI). They must either have a provider's diagnosis of CI, score between 13-18 on the T-MoCA test, or feel they have memory issues. Excluded are those in assisted living, non-English speakers, participants in similar services, those unwilling or unable to engage actively in the intervention, and individuals with untreated mental health conditions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Phase I: Development and Adaptation
Participants engage in the Home Alone intervention to identify treatment components and examine feasibility and relevance.
Phase II: Pilot Testing
Pilot test a revised version of Home Alone to evaluate implementation potential, feasibility, acceptability, and usefulness.
Follow-up
Participants are monitored for safety and effectiveness after the intervention.
Treatment Details
Interventions
- Home Alone
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor